News Release For Immediate Distribution May 31, 2002 FHC, Inc. acquires sales, technical support and manufacturing rights for Axon Guideline 3000A Intraoperative Microrecording System.   In a joint announcement, Axon Instruments, Inc. and FHC, Inc. revealed that FHC will, effective June 01, 2002, assume the sales, technical support, and manufacturing responsibilities for the Axon Guideline® clinical product line.   "Axon Instruments is focusing all of its efforts toward instrumentation for the drug discovery process. However, we wanted to make sure these excellent products continued to be offered," said Andy Blatz, Ph.D., Axon Instruments Vice President for Cell Based Screening. "By transferring the Guideline System to FHC, whose product mix matches the intraoperative recording, stimulation and data analysis requirements of the functional neurosurgeons and neurologists who use this technology, we assure our clinical customers of the continued quality service and support for which we are known. Many of our customers already use FHC's microelectrodes, so supplyline issues will be minimized."   "Axon Instruments is recognized as a 'gold standard' instrument manufacturer in the research, neuroscience and biotech markets," Mike Graffam, FHC Engineering Manager, said while at the Axon Facility overseeing the inventory transfer. FHC Allen Groleau, added, "By adding the Guideline System to our stereotactic positioners, guidance systems, and technical support we will now be able to offer a complete, FDA cleared, procedural solution for targeting during movement disorder surgery."   Axon Instruments, Inc., located in Union City, California and Melbourne, Australia, was founded in 1984. It produces a broad spectrum of instrumentation and software for genomics, cellular neurosciences and cell-based screening. In genomics and cellular neurosciences, Axon is already widely recognized as a pre-eminent manufacturer. The company's goal is to produce a range of superior yet affordable instrument and software systems for drug discovery ained at the pharmaceutical industry, biotechnology companies and academic researchers. Axon Instruments is a California corporation listed on the Australian Stock Exchange (symbol: AXN.AX).   For more information, regarding Axon products, please call Al Walter, PhD. (510) 675-6200 or alw@axon.com.   FHC, Inc. is a privately held corporation located in Bowdoinham, Maine. Founded in 1970, FHC manufactures and markets Neurocraft(TM) microelectrodes, electronic and mechanical instrumentation and data analysis products to neuroscience research investigators who use extracellular methods and microTargeting®, FDA cleared, products to functional neurosurgeons and neurologists.   For additional information, please contact Kari Thormodsgard, FHC Sales Coordinator, at (207) 666-8190 or visit their website at www.fh-co.com.